Literature DB >> 26930534

Behavioral interventions for antipsychotic medication-associated obesity: a randomized, controlled clinical trial.

Zachary D Erickson1, Shirley J Mena, Joseph M Pierre, Lisa H Blum, Eda Martin, Gerhard S Hellemann, Dixie R Aragaki, Lisa Firestone, Catherine Lee, Paul Lee, Charles F Kunkel, Donna Ames.   

Abstract

OBJECTIVE: To demonstrate the effectiveness of a Diabetes Prevention Program-inspired 12-month behavioral intervention for patients with severe mental illness (SMI) and medication-associated obesity.
METHOD: This randomized, controlled, parallel, superiority study screened 225 volunteers from November 2005 to August 2008 at the VA Greater Los Angeles Healthcare System. 122 outpatients with DSM-IV-diagnosed SMI taking antipsychotic medications who had ≥ 7% weight gain or body mass index (BMI) > 25 were randomized by computer-generated number to Lifestyle Balance treatment intervention (n = 60) or usual care control (n = 62) groups. Clinical raters were masked to randomization. Treatment intervention included weekly classes and individual counseling for 8 weeks, food and exercise diaries, rewards, caregiver consultations, and monthly booster classes and counseling for 1 year. Controls received self-help materials and visited at equivalent intervals without formal classes or counseling. Outcomes were changes in anthropometric measurements, psychiatric symptoms, health knowledge, and glucose, hemoglobin A1c, and lipid levels.
RESULTS: Our intention-to-treat analysis found significant differences in predicted trajectory of mean weight change between the groups over 12 months (P < .01), with treatment participants expected to lose an average 4.6 kg, while control participants would gain an average 0.6 kg. BMI and body fat percentage followed the same pattern. Both groups demonstrated statistically significant improvements in health knowledge quiz scores over time (P = .006), without significant difference between groups.
CONCLUSIONS: Treatment was more effective than usual care control in treating medication-associated obesity, independent of SMI diagnosis, antipsychotic medication, and knowledge gained, suggesting that behavioral interventions are effective in SMI patients. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00344500. © Copyright 2016 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26930534     DOI: 10.4088/JCP.14m09552

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  9 in total

1.  Adiposity, Hepatic Triglyceride, and Carotid Intima Media Thickness During Behavioral Weight Loss Treatment in Antipsychotic-Treated Youth: A Randomized Pilot Study.

Authors:  Ginger E Nicol; Rachel Kolko; Eric J Lenze; Michael D Yingling; J Philip Miller; Amanda R Ricchio; Julia A Schweiger; Robert L Findling; Denise Wilfley; John W Newcomer
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-04-17       Impact factor: 2.576

Review 2.  Lifestyle interventions for weight loss among overweight and obese adults with serious mental illness: A systematic review and meta-analysis.

Authors:  John A Naslund; Karen L Whiteman; Gregory J McHugo; Kelly A Aschbrenner; Lisa A Marsch; Stephen J Bartels
Journal:  Gen Hosp Psychiatry       Date:  2017-04-06       Impact factor: 3.238

3.  A Randomized, Controlled Multisite Study of Behavioral Interventions for Veterans with Mental Illness and Antipsychotic Medication-Associated Obesity.

Authors:  Zachary D Erickson; Crystal L Kwan; Hollie A Gelberg; Irina Y Arnold; Valery Chamberlin; Jennifer A Rosen; Chandresh Shah; Charles T Nguyen; Gerhard Hellemann; Dixie R Aragaki; Charles F Kunkel; Melissa M Lewis; Neena Sachinvala; Patrick A Sonza; Joseph M Pierre; Donna Ames
Journal:  J Gen Intern Med       Date:  2017-04       Impact factor: 5.128

4.  Barriers to participation in web-based and in-person weight management interventions for serious mental illness.

Authors:  Tanya T Olmos-Ochoa; Noosha Niv; Gerhard Hellemann; Amy N Cohen; Rebecca Oberman; Richard Goldberg; Alexander S Young
Journal:  Psychiatr Rehabil J       Date:  2019-05-13

5.  Recommendations of the Schizophrenia Expert Center network for adequate physical activity in real-world schizophrenia (FACE-SZ).

Authors:  Pierre-Louis Sunhary De Verville; Brendon Stubbs; Damien Etchecopar-Etchart; Ophélia Godin; Christelle Andrieu-Haller; Fabrice Berna; Bruno Aouizerate; Delphine Capdevielle; Isabelle Chereau; Julie Clauss-Kobayashi; Nathalie Coulon; Jean-Michel Dorey; Caroline Dubertret; Sylvain Leignier; Jasmina Mallet; David Misdrahi; Catherine Passerieux; Baptiste Pignon; Romain Rey; Mathieu Urbach; Pierre-Michel Llorca; Franck Schürhoff; Christophe Lançon; Laurent Boyer; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-04-20       Impact factor: 5.760

6.  Interventions for the management of obesity in people with bipolar disorder.

Authors:  Agnes Tully; Siobhan Smyth; Yvonne Conway; John Geddes; Declan Devane; John P Kelly; Fionnuala Jordan
Journal:  Cochrane Database Syst Rev       Date:  2020-07-20

7.  Clinical Correlates of Insulin Resistance in Chronic Schizophrenia: Relationship to Negative Symptoms.

Authors:  Virawudh Soontornniyomkij; Ellen E Lee; Hua Jin; Averria Sirkin Martin; Rebecca E Daly; Jinyuan Liu; Xin M Tu; Lisa Todd Eyler; Dilip V Jeste
Journal:  Front Psychiatry       Date:  2019-04-23       Impact factor: 4.157

8.  Patient-reported outcomes of lifestyle interventions in patients with severe mental illness: a systematic review and meta-analysis.

Authors:  Laura M Pape; Marcel C Adriaanse; Jelle Kol; Annemieke van Straten; Berno van Meijel
Journal:  BMC Psychiatry       Date:  2022-04-13       Impact factor: 3.630

Review 9.  Systematic review of lifestyle interventions to improve weight, physical activity and diet among people with a mental health condition.

Authors:  Tegan Bradley; Elizabeth Campbell; Julia Dray; Kate Bartlem; Paula Wye; Grace Hanly; Lauren Gibson; Caitlin Fehily; Jacqueline Bailey; Olivia Wynne; Kim Colyvas; Jenny Bowman
Journal:  Syst Rev       Date:  2022-09-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.